Involvement of miR17 pathway in glucocorticoid-induced cell death in pediatric acute lymphoblastic leukemia

Leukemia and Lymphoma

Volumn 53, Issue 10, 2012, Pages 2041-2050

  Harada, Masako ^a   Pokrovskaja Tamm, Katja ^a   Söderhäll, Stefan ^b   Heyman, Mats ^b   Grander, Dan ^a   Corcoran, Martin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cell cycle and apoptosis; Changes; Chemotherapeutic approaches; Drug resistance; Lymphoid leukemia; Molecular genetics; Pharmacotherapeutics

Indexed keywords

BIM PROTEIN; DEXAMETHASONE; MICRORNA; MICRORNA 17; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; EX VIVO STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; CHILD; DEXAMETHASONE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GLUCOCORTICOIDS; HUMANS; MEMBRANE PROTEINS; MICRORNAS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84865756287     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.678004     Document Type: Article

References (42)

1. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet 2008;371:1030-1043.
2. Inaba H, Pui CH. Glucocorticoid use in acute lymphoblastic leukaemia. Lancet Oncol 2010;11:1096-1106.
3. General information about childhood acute lymphoblastic leukemia (ALL) [Internet]. 2011. Available from: http://www.cancer. gov/cancertopics/pdq/ treatment/childALL/HealthProfessional
4. Kumar R, Thompson EB. Gene regulation by the glucocorticoid receptor: structure:function relationship. JSteroid Biochem Mol Biol 2005;94:383-394.
5. Kassel O, Herrlich P. Crosstalk between the glucocorticoid receptor and other transcription factors: molecular aspects. Mol Cell Endocrinol 2007;275:13-29.
6. Rao NA, McCalman MT, Moulos P, et al. Coactivation of GRand NFKBalters the repertoire of their binding sites and target genes. Genome Res 2011;21:1404-1416.
7. Schlossmacher G, Stevens A, White A. Glucocorticoid receptormediated apoptosis: mechanisms of resistance in cancer cells. JEndocrinol 2011;211:17-25.
8. Miller AL, Komak S, Webb MS, et al. Gene expression profiling of leukemic cells and primary thymocytes predicts a signature for apoptotic sensitivity to glucocorticoids. Cancer Cell Int 2007;7:18.
9. Chauhan S, Leach CH, Kunz S, et al. Glucocorticoid regulation of human eosinophil gene expression. JSteroid Biochem Mol Biol 2003;84:441-452.
10. Obexer P, Certa U, Kofler R, et al. Expression profiling of glucocorticoid-treated T-ALLcell lines: rapid repression of multiple genes involved in RNA-, protein-and nucleotide synthesis. Oncogene 2001;20:4324-4336.
11. Rainer J, Ploner C, Jesacher S, et al. Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia. Leukemia 2009;23:746-752.
12. Sun W, Julie Li YS, Huang HD, et al. microRNA: a master regulator of cellular processes for bioengineering systems. Annu Rev Biomed Eng 2010;12:1-27.
13. Landgraf P, Rusu M, Sheridan R, et al. Amammalian microRNAexpression atlas based on small RNAlibrary sequencing. Cell 2007;129:1401-1414.
14. McCormick R, Buffa FM, Ragoussis J, et al. The role of hypoxia regulated microRNAs in cancer. Curr Topics Microbiol Immunol 2010;345:47-70.
15. Mestdagh P, Fredlund E, Pattyn F, et al. MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors. Oncogene 2010;29: 1394-1404.
16. Bueno MJ, Gomez de Cedron M, Laresgoiti U, et al. Multiple E2Finduced microRNAs prevent replicative stress in response to mitogenic signaling. Mol Cell Biol 2010;30:2983-2995.
17. Batchelor E, Loewer A, Lahav G. The ups and downs of p53: understanding protein dynamics in single cells. Nat Rev Cancer 2009; 9:371-377.
18. Song B, Wang Y, Xi Y, et al. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene 2009;28:4065-4074.
19. Ribas J, Ni X, Haffner M, et al. miR-21: an androgen receptorregulated microRNAthat promotes hormone-dependent and hormone-independent prostate cancer growth. Cancer Res 2009;69: 7165-7169.
20. Zhao Y, Deng C, Lu W, et al. let-7 microRNAs induce tamoxifen sensitivity by down-regulation of estrogen receptor alpha signaling in breast cancer. Mol Med 2011;17:1233-1241.
21. Boyd KE, Wells J, Gutman J, et al. c-Myc target gene specificity is determined by a post-DNAbinding mechanism. Proc Natl Acad Sci USA1998;95:13887-13892.
22. Laane E, Tamm KP, Buentke E, et al. Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy. Cell Death Differ 2009;16:1018-1029.
23. Laane E, Panaretakis T, Pokrovskaja K, et al. Dexamethasoneinduced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members. Haematologica 2007; 92:1460-1469.
24. Lu J, Getz G, Miska EA, et al. MicroRNAexpression profiles classify human cancers. Nature 2005;435:834-838.
25. Tsang JS, Ebert MS, van Oudenaarden A. Genome-wide dissection of microRNAfunctions and cotargeting networks using gene set signatures. Mol Cell 2010;38:140-153.
26. He L, Thomson JM, Hemann MT, et al. AmicroRNApolycistron as a potential human oncogene. Nature 2005;435:828-833.
27. Hayashita Y, Osada H, Tatematsu Y, et al. Apolycistronic microRNAcluster, miR-17-92, is overexpressed in human lung cancers andenhances cell proliferation. Cancer Res 2005;65:9628-9632.
28. Mendell JT. miRiad roles for the miR-17-9 2 cluster in development and disease. Cell 2008;133:217-222.
29. van Haaften G, Agami R. Tumorigenicity of the miR-17-92 cluster distilled. Genes Dev 2010;24:1-4.
30. Ventura A, Young AG, Winslow MM, et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNAclusters. Cell 2008;132:875-886.
31. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215-233.
32. Ploner C, Rainer J, Niederegger H, et al. The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia. Leukemia 2008;22:370-377.
33. Fontana L, Fiori ME, Albini S, et al. Antagomir-17-5 p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoSOne 2008;3:e2236.
34. Smith LK, Shah RR, Cidlowski JA. Glucocorticoids modulate microRNAexpression and processing during lymphocyte apoptosis. JBiol Chem 2010;285:36698-36708.
35. Tang X, Li M, Tucker L, et al. Glycogen synthase kinase 3 beta (GSK3beta) phosphorylates the RNAase IIIenzyme Drosha at S300 and S302. PLoSOne 2011;6:e20391.
36. Failor KL, Desyatnikov Y, Finger LA, et al. Glucocorticoid-induced degradation of glycogen synthase kinase-3 protein is triggered by serum-and glucocorticoid-induced protein kinase and Akt signaling and controls beta-catenin dynamics and tight junction formation in mammary epithelial tumor cells. Mol Endocrinol 2007;21:2403-2415.
37. Lv M, Zhang X, Jia H, et al. An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-alpha and cAMP/PKApathways. Leukemia 2012;26:769-777.
38. Rao X, Di Leva G, Li M, et al. MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene 2011;30:1082-1097.
39. Kong W, He L, Coppola M, et al. MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. JBiol Chem 2010;285:17869-17879.
40. Molitoris JK, McColl KS, Distelhorst CW. Glucocorticoidmediated repression of the oncogenic microRNAcluster miR-17 ~?92 contributes to the induction of Bim and initiation of apoptosis. Mol Endocrinol 2011;25:409-420.
41. Zhang H, Luo XQ, Feng DD, et al. Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia. Mol Cancer 2011;10:108.
42. Lu J, Quearry B, Harada H. p38-MAPkinase activation followed by BIMinduction is essential for glucocorticoid-induced apoptosis in lymphoblastic leukemia cells. FEBSLett 2006;580:3539-3544.